Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
lestaurtinib receptor-type tyrosine-protein kinase flt3 small molecule NA drugbank , DGIDB leukemia[MeSHID:D007938]
Pancreatic carcinoma[MeSHID:C562463]
Malignant neoplasm of pancreas[MeSHID:D010190]
Malignant neoplasm of prostate[MeSHID:D011471]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Myeloid Leukemia[MeSHID:D007951]
Leukemia
Myelocytic
Acute[MeSHID:D015470]
Psoriasis[MeSHID:D011565]		 1.99 investigational unknown
lestaurtinib receptor-type tyrosine-protein kinase flt3 small molecule NA drugbank , DGIDB leukemia[MeSHID:D007938]
Pancreatic carcinoma[MeSHID:C562463]
Malignant neoplasm of pancreas[MeSHID:D010190]
Malignant neoplasm of prostate[MeSHID:D011471]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Myeloid Leukemia[MeSHID:D007951]
Leukemia
Myelocytic
Acute[MeSHID:D015470]
Psoriasis[MeSHID:D011565]		 1.99 investigational inhibitor
lestaurtinib fms-like tyrosine kinase 3 NA Successful target TTD , DGIDB leukemia[MeSHID:D007938]
Pancreatic carcinoma[MeSHID:C562463]
Malignant neoplasm of pancreas[MeSHID:D010190]
Malignant neoplasm of prostate[MeSHID:D011471]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Myeloid Leukemia[MeSHID:D007951]
Leukemia
Myelocytic
Acute[MeSHID:D015470]
Psoriasis[MeSHID:D011565]		 1.99 approved (orphan drug) unknown
lestaurtinib fms-like tyrosine kinase 3 NA Successful target TTD , DGIDB leukemia[MeSHID:D007938]
Pancreatic carcinoma[MeSHID:C562463]
Malignant neoplasm of pancreas[MeSHID:D010190]
Malignant neoplasm of prostate[MeSHID:D011471]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Myeloid Leukemia[MeSHID:D007951]
Leukemia
Myelocytic
Acute[MeSHID:D015470]
Psoriasis[MeSHID:D011565]		 1.99 approved (orphan drug) inhibitor
click here to return to the previous page